Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Chronic Fatigue Research Mechanism: Protocol Comparison

Chronic restraint stress (mouse) 10 mcg/kg Intraperitoneal 14 days ATP synthesis capacity in skeletal muscle +34% restoration vs untreated Demonstrates mitochondrial mechanism; short duration limits long-term inference Chronic unpredictable mild stress (rat) S

This comparison does not assign a generated winner or score.

  • Chronic restraint stress (mouse)
  • 10 mcg/kg
  • Intraperitoneal
  • 14 days
  • ATP synthesis capacity in skeletal muscle
  • +34% restoration vs untreated
  • Demonstrates mitochondrial mechanism; short duration limits long-term inference
  • Chronic unpredictable mild stress (rat)
  • Subcutaneous
  • 21 days
  • Serum IL-6 and TNF-α levels
  • −38% IL-6, −42% TNF-α
  • Strong anti-inflammatory effect; behavioral improvements align with cytokine reduction
  • Experimentally induced colitis (rat)
  • 10 days
  • Intestinal permeability (FITC-dextran) and treadmill endurance
  • −46% permeability, +28% endurance time
  • Gut-brain axis mechanism validated; systemic fatigue improved via barrier repair
  • Post-ischemic injury (rat)
  • 10–20 mcg/kg
  • Capillary density in affected tissue
  • +52% vascular density at 20 mcg/kg
  • Dose-dependent angiogenesis; higher doses required for vascular repair vs inflammation
More references

Related material